Intravitreal Ranibizumab For Persistent New Vessels In Diabetic Retinopathy(Inipe Study)
Status:
Unknown status
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
To evaluate the fluorescein angiographic and visual acuity effects of a single intravitreal
injection of ranibizumab for the management of persistent new vessels associated with
diabetic retinopathy.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of Sao Paulo
Collaborators:
Fundação de Amparo à Pesquisa do Estado de São Paulo Fundação de Apoio ao Ensino Pesquisa e Assitência do HCFMRPUSP (FAEPA)